Substance / Medication

Methamphetamine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Narcolepsy

Attention deficit hyperactivity disorder

Obesity

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Cholesterol

LOINC 2093-3

secondary

Hemoglobin A1c

LOINC 4549-2

secondary

Triglyceride

LOINC 2571-8

secondary

Clinical Trials

426 trials linked to this intervention

426

Total Trials

122

Recruiting

109

With Results

Recent Trials

Diabetes and Heart Disease Risk in Blacks

NCT00001853Recruiting2000 enrolled

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

NCT00009555Phase 4Completed86 enrolled

Pediatric Hypothalamic Obesity

NCT00076362Phase 4Completed60 enrolled

The Safety and Effectiveness of Low and High Carbohydrate Diets

NCT00079547Phase 4Completed307 enrolled

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

NCT00134303Phase 4Completed65 enrolled

View all 426 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Piezoelectric suppression for rapid detection of Methamphetamine Hydrochloride viaN nuclear quadrupole resonance.

Robertson Lewis, Yong Richard, Miljak David G · Solid State Nucl Magn Reson · 2025

PMID: 40795415Other

Handheld UV spectrophotometer device for detection of methamphetamine hydrochloride based on supramolecular sensing platform.

Ran Xin, Yu Yanbo, Yang Hongxing et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2024

PMID: 37832445Other

Comparison and evaluation of the quick purification methods of methamphetamine hydrochloride from dimethyl sulfone for spectroscopic identification.

Segawa Hiroki, Kumisaka Kento, Sugita Ritsuko et al. · Forensic Sci Int · 2018

PMID: 29174515Other

Synthesis of novel sonocatalyst Er:YAlO/NbOand its application for sonocatalytic degradation of methamphetamine hydrochloride.

Wei Chunsheng, Yi Kuiyu, Sun Guangsheng et al. · Ultrason Sonochem · 2018

PMID: 29429705Other

Synthesis and organic impurity profiling of 4-methoxymethamphetamine hydrochloride and its precursors.

Tam Rebecca, Heather Erin, Shimmon Ronald et al. · Forensic Sci Int · 2017

PMID: 28065556Other

Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces II. Skin surface contact and dermal transfer relationship.

Salocks Charles B, Hui Xiaoying, Lamel Sonia et al. · Food Chem Toxicol · 2014

PMID: 24440561Other

Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces: surface pH values, volatility, and in vitro human skin.

Salocks Charles B, Hui Xiaoying, Lamel Sonia et al. · Food Chem Toxicol · 2012

PMID: 22902806Other

An electrochemiluminescent sensor for methamphetamine hydrochloride based on multiwall carbon nanotube/ionic liquid composite electrode.

Dai Hong, Wang Youmei, Wu Xiaoping et al. · Biosens Bioelectron · 2009

PMID: 18760586Other

Prenatal methamphetamine hydrochloride exposure downregulates miRNA-151-3p and CACNA1C in testis rats' offspring.

Bakhshaei Romina, Zare Nayere, Baghi Zadeh Zahra et al. · Cell Mol Biol (Noisy-le-grand) · 2024

PMID: 39097871Preclinical

Prenatal Methamphetamine Hydrochloride Exposure Leads to Signal Transduction Alteration and Cell Death in the Prefrontal Cortex and Amygdala of Male and Female Rats' Offspring.

Zare Nayereh, Maghsoudi Nader, Mirbehbahani Seyed Hamidreza et al. · J Mol Neurosci · 2022

PMID: 36056281Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Obesity Medicine (Family Medicine) Physician

Family Medicine — Obesity Medicine

NUCC 207QB0002X

Obesity Medicine (Internal Medicine) Physician

Internal Medicine — Obesity Medicine

NUCC 207RB0002X

Endocrinology, Diabetes & Metabolism Physician

Internal Medicine — Endocrinology, Diabetes & Metabolism

NUCC 207RE0101X

Find a Provider

Health Goals

Goals connected through associated conditions

Manage Weight and Body Composition Optimize Metabolic Function

Quick Facts

Type: Substance / Medication
Fully Specified Name: Methamphetamine hydrochloride (substance)
SNOMED CT: 387329009
UMLS CUI: C0282233

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

426

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.